phosphoramides

Preferred Label : phosphoramides;

MeSH definition : Amide derivatives of phosphoric acid such as compounds that include the phosphoric triamide (P( O)(N)(N)(N)) structure.;

Is substance : O;

Détails

Origin ID

D063088;

UMLS CUI

C3494394;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- phosphoramides [IUPAC Term]
Record concept(s)
- phosphoramides [MeSH concept]
Related MeSH Supplementary Concept(s)
- 4-methoxyphenyl 6-O-methyl-phosphoramidylgalactopyranoside [MeSH Supplementary Concept]
- AT-511 [MeSH Supplementary Concept]
- N,N'-diethylene-N''-(5-methyl-1,3,4-thiadiazol-2-yl)phosphoramide [MeSH Supplementary Concept]
- acephate [MeSH Supplementary Concept]
- adafosbuvir [MeSH Supplementary Concept]
- dexamethasone-(C21-phosphoramide)-(anti-EGFR) [MeSH Supplementary Concept]
- lutetium aminophosphonate [MeSH Supplementary Concept]
- phosphoramide [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients